Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection

J Xu1, P Dennehy, H Keyserling

  • 1Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Emory University School of Medicine, Atlanta, Georgia, USA.

Insights

Serum immunoglobulin G (IgG) is the most reliable marker for rotavirus infection seroconversion and predicts protection against severe disease. Maternal antibodies can impact infant immune responses to rotavirus infection.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Rotavirus is a leading cause of severe diarrheal disease in infants globally.
  • Maternal antibodies can influence infant immune responses to infections.
  • Understanding antibody markers for rotavirus infection is crucial for disease management.

Purpose of the Study:

  • To investigate immunoglobulin M (IgM), IgA, and IgG antibody responses to rotavirus in infants.
  • To determine if serum antibody titers can predict rotavirus disease severity.
  • To assess the role of maternal antibodies in infant rotavirus infections.

Main Methods:

  • Sera from 42 patients aged 1–30 months were analyzed for rotavirus-specific IgM, IgA, IgG, and IgG subclasses.
  • Antibody titers in acute- and convalescent-phase sera were measured.
  • Correlation between antibody levels and disease severity/duration was assessed.

Main Results:

  • IgM was a reliable marker for acute rotavirus infection in patients aged ≥6 months.
  • IgG seroconversion was observed in 81% of patients, making it the best overall infection predictor.
  • Higher IgA responses were seen in children ≥12 months.
  • Preexisting IgG titers ≥100 or ≥200 correlated with less severe or shorter diarrhea.
  • IgG1 was the predominant IgG subclass detected.

Conclusions:

  • Serum IgG is the most reliable marker for rotavirus infection seroconversion.
  • Serum IgG serves as a consistent proxy for protection against severe rotavirus disease.
  • Maternal IgG antibodies may inhibit viral replication and infant antibody responses in early life.